aboutus
 

Executive Management

 josh_s Joshua Levine was appointed Chief Executive Officer of XTL in October 2013. From January 2011 until September 2013 Josh served as the Chief Executive Officer of Proteologics (TASE: PRTL). From September 2008 until September 2010, he was Chairman of the Board of Proteologics Ltd. Concurrently, he was Senior Director at Teva Innovative Ventures responsible for, among other things, business development as well as alliance management for the unit. He has also held several executive positions within venture capital funds and boutique investment banks. Previously, he was a corporate attorney at a large New York City law firm. Mr. Levine holds a JD degree from Columbia University Law School and a BA degree in Chemistry from Yeshiva University.
DSC_0940_s2 David Kestenbaum has served as Chief Financial Officer in our Company since January 2014. Previously, from 2010 to 2012, he served as CFO of Zenith Solar Ltd., a start-up company involved in the development and deployment of innovative solar energy technology. Prior positions include Finance Director of Colbar Lifescience Ltd., a medical device/biotech company and division of Johnson and Johnson (NYSE:JNJ) from 2007 to 2010, CFO of ZAG Industries Ltd., a division of The Stanleyworks (NYSE:SWK) from 2003 to 2007, and CFO and other senior financial positions at affiliates of Unilever NV (NYSE: UN) in the US and Israel. Before entering the industry, he worked in public accounting at PriceWaterhouseCoopers in NY from 1986 to 1990. Mr. Kestenbaum is a US Certified Public Accountant and holds a BSc in Accounting from Yeshiva University (NY), and a MBA in Finance and International Business from Columbia University (NY).
 Daphna Paran Dr. Daphna Paran has served as Medical Director of the Company since March 2016.  Dr. Paran has over 20 years of rheumatology expertise with a focus on lupus.  She is a senior lecturer at Tel Aviv University, the head of the lupus clinic, head of the rheumatology day care unit and the deputy head of the Department of Rheumatology at the Tel Aviv Medical Center (Ichilov Hospital). She completed her medical studies at Ben Gurion University, trained in lupus and the antiphospholipid syndrome at the lupus unit, Rayne Institute, St. Thomas’ Hospital in London and has published or co-authored over 60 articles in the field of lupus and rheumatology.